SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-17-035035
Filing Date
2017-06-29
Accepted
2017-06-29 21:03:31
Documents
1
Period of Report
2017-06-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 v470076_form4.html 4  
1 FORM 4 v470076_form4.xml 4 6025
  Complete submission text file 0001144204-17-035035.txt   7412
Mailing Address 450 W. 15TH STREET SUITE 505 New York NY 10011
Business Address 450 W. 15TH STREET SUITE 505 NEW YORK NY 10011 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Issuer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMAG PHARMACEUTICALS, INC. 1100 WINTER STREET WALTHAM MA 02451
Business Address
SANTINI GINO (Reporting) CIK: 0001276038 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35668 | Film No.: 17940019